The effect of clinical trial participation versus non-participation on overall survival in men receiving first-line docetaxel-containing chemotherapy for metastatic castration-resistant prostate cancer

OBJECTIVE: To study differences in baseline characteristics and outcomes of patients with metastatic castration-resistant prostate cancer (mCRPC) receiving first-line docetaxel-containing chemotherapy on prospective clinical studies (trial participants) versus those receiving this therapy outside of...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Goyal, Jatinder, Nuhn, Philipp, Huang, Peng, Tyagi, Prachi, Oh, Daniel, Carducci, Michael A., Eisenberger, Mario A., Antonarakis, Emmanuel S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2012
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3715077/
https://ncbi.nlm.nih.gov/pubmed/22702837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1464-410X.2012.11286.x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak